Rosubar 5mg Tablet Hitop Tablet The extended-release formulation provides steady
Rosubar 5mg Tablet Hitop Tablet The extended-release formulation provides steadyThe indications for rosuvastatin treatment include mixed dyslipidemia and hyperlipidemia. In adult patients with primary hyperlipidemia or mixed dyslipidemia, as an adjuvant therapy to diet to enhance HDL C and decrease high Total C, LDL C, ApoB, nonHDL C, and triglycerides.
Pay in 4 interest-free payments of $3.73 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26